Targeting focal adhesion kinase: from molecular mechanisms to next-generation cancer therapeutics
Top Cited Papers
- 27 February 2026
- journal article
- review article
- Published by Elsevier in Science Bulletin
- Vol. 71 (7) , 1812-1830
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 268 references indexed in Scilit:
- NAT10 regulates tumor progression and immune microenvironment in pancreatic ductal adenocarcinoma via the N4‐acetylated LAMB3‐mediated FAK/ERK pathwayCancer Communications, 2025
- A protein complex of LCN2, LOXL2 and MMP9 facilitates tumour metastasis in oesophageal cancerMolecular Oncology, 2023
- Tumor‐associated macrophages in liver cancer: From mechanisms to therapyCancer Communications, 2022
- An Inter‐Supplementary Biohybrid System Based on Natural Killer Cells for the Combinational Immunotherapy and Virotherapy of CancerAdvanced Science, 2021
- Discovery and Characterisation of Highly Cooperative FAK‐Degrading PROTACsAngewandte Chemie International Edition, 2021
- NOX5 mediates the crosstalk between tumor cells and cancer‐associated fibroblasts via regulating cytokine networkClinical and Translational Medicine, 2021
- S100A7 as a potential diagnostic and prognostic biomarker of esophageal squamous cell carcinoma promotes M2 macrophage infiltration and angiogenesisClinical and Translational Medicine, 2021
- Focal adhesion kinase (FAK) inhibitor‐defactinib suppresses the malignant progression of human esophageal squamous cell carcinoma (ESCC) cells via effective blockade of PI3K/AKT axis and downstream molecular networkMolecular Carcinogenesis, 2020
- Epithelial‐to‐Mesenchymal Transition in Paclitaxel‐Resistant Ovarian Cancer Cells Is Downregulated by LuteolinJournal of Cellular Physiology, 2016
- Inhibition of FAK and VEGFR‐3 binding decreases tumorigenicity in neuroblastomaMolecular Carcinogenesis, 2013